NasdaqGM - Delayed Quote • USD
CareDx, Inc (CDNA)
At close: April 19 at 4:00 PM EDT
After hours: April 19 at 4:04 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 5 |
| Avg. Estimate | -0.19 | -0.14 | -0.53 | -0.46 |
| Low Estimate | -0.21 | -0.18 | -0.68 | -1.1 |
| High Estimate | -0.17 | -0.09 | -0.39 | -0.19 |
| Year Ago EPS | -0.11 | -0.18 | -0.64 | -0.53 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 7 | 6 |
| Avg. Estimate | 63.5M | 65.46M | 266.61M | 285.35M |
| Low Estimate | 62M | 64.7M | 264.1M | 278.9M |
| High Estimate | 64.9M | 65.76M | 269.06M | 294.35M |
| Year Ago Sales | 77.26M | -- | 280.32M | 266.61M |
| Sales Growth (year/est) | -17.80% | -- | -4.90% | 7.00% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.11 | -0.31 | -0.39 | -0.27 |
| EPS Actual | -0.11 | -0.18 | -0.18 | -0.17 |
| Difference | 0 | 0.13 | 0.21 | 0.1 |
| Surprise % | 0.00% | 41.90% | 53.80% | 37.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.19 | -0.14 | -0.53 | -0.46 |
| 7 Days Ago | -0.19 | -0.14 | -0.53 | -0.46 |
| 30 Days Ago | -0.19 | -0.14 | -0.53 | -0.46 |
| 60 Days Ago | -0.21 | -0.17 | -0.62 | -0.37 |
| 90 Days Ago | -0.19 | -0.16 | -0.61 | -0.34 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | CDNA | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -72.70% | -- | -- | 1.60% |
| Next Qtr. | 22.20% | -- | -- | 10.50% |
| Current Year | 17.20% | -- | -- | 5.20% |
| Next Year | 13.20% | -- | -- | 13.30% |
| Next 5 Years (per annum) | 20.00% | -- | -- | 11.22% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Reiterates | Stephens & Co.: Overweight to Overweight | 4/17/2024 |
| Upgrade | Stephens & Co.: Equal-Weight to Overweight | 11/9/2023 |
| Reiterates | Stephens & Co.: Equal-Weight to Equal-Weight | 9/26/2023 |
| Upgrade | Raymond James: Market Perform to Outperform | 8/15/2023 |
| Reiterates | HC Wainwright & Co.: Neutral | 8/9/2023 |
| Maintains | Raymond James: Market Perform to Market Perform | 7/11/2023 |
Related Tickers
PSNL Personalis, Inc.
1.2900
+6.61%
VCYT Veracyte, Inc.
19.45
+1.30%
TWST Twist Bioscience Corporation
27.95
-1.45%
CSTL Castle Biosciences, Inc.
19.31
+0.57%
MYGN Myriad Genetics, Inc.
18.50
-0.05%
BDSX Biodesix, Inc.
1.2500
0.00%
GH Guardant Health, Inc.
16.07
-3.60%
NTRA Natera, Inc.
85.28
-2.29%
FLGT Fulgent Genetics, Inc.
20.36
+1.24%
DMTK DermTech, Inc.
0.6440
+8.97%